Clinical Trials

The clinical trials below are available in the specialty you selected. Choose a different specialty.

A randomized, double-blind, placebo controlled study to assess the efficacy of LCQ908 on cardiovascular risk
This study is a proof of concept to determine if an investigational drug called LCQ908 can reduce triglyceride levels and lessen cardiovascular risk in people with cardiovascular disease. (REF# 35097)

Act One
The purpose of this clinical trial is to evaluate the carotid stent vs. surgery trial by studying individuals with carotid stenosis. (REF# 10162)

SAPPHIRE World Wide Registry
Duke Cardiac Catheterization Lab is seeking research subjects with carotid stenosis to participate in a carotid stent high-risk registry. (REF# 2225)

Studies of a Targeted Risk Reduction Intervention Through Defined Exercise in Pre-Diabetics: STRRIDE-PD
This study seeks participants between 45 and 75 years of age to evaluate the effects of different amounts and intensities of aerobic exercise. (REF# 12628)

Everest II
This study seeks adults with mitral regurgitation (MR) who are seeking treatment for their condition. (REF# 11826)

IMPACT Study
This study seeks adults who are candidates for implantation of, or already implanted with, a BIOTRONIK Lumax HF-T or DR-T device. (REF# 19400)

CABANA Trial
This study seeks adult participants who have been diagnosed with an abnormal heart rhythm called atrial fibrillation (AF). (REF# 18744)

Medtronic CoreValve U.S. Pivotal Trial
Researchers are seeking patients with severe degenerative aortic valve disease to participate in this study. (REF# 26293)